Pfizer offers funding to qualified 501(c)(3) organizations for certain healthcare-related programs/activities for patients. This type of support is limited to the following: 1) patient education, including health screening; 2) patient advocacy for disease awareness, and 3) patient access to care (e.g., transportation costs).
In the highly regulated and competitive pharmaceutical industry, it is crucial to our stakeholders that we engage in public policy issues that may affect our ability to meet patient needs and enhance shareholder value. This site contains information around corporate and employee Political Action Committee contributions.
Pfizer offers funding for independent medical education activities or initiatives which serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (e.g. continuing medical education, continuing health education, continuing education.) These activities or initiatives may or may not be accredited.
Pfizer is able to support investigators in conducting their own research by providing funding and/or drug/pure compound for pre-clinical, early clinical, and late clinical research through the Investigator Sponsored Research program.